As of 2025-07-02, the Relative Valuation of Syros Pharmaceuticals Inc (SYRS) is (197.71) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.12 USD, the upside of Syros Pharmaceuticals Inc based on Relative Valuation is -168796.7%.
The range of the Relative Valuation is (151.81) - (275.74) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 8.5x - 18.2x | 12.8x |
| Forward P/E multiples | 10.0x - 20.7x | 13.3x |
| Fair Price | (151.81) - (275.74) | (197.71) |
| Upside | -129628.1% - -235370.5% | -168796.7% |
| Date | P/E |
| 2025-06-30 | -0.00 |
| 2025-06-27 | -0.00 |
| 2025-06-26 | -0.00 |
| 2025-06-25 | -0.00 |
| 2025-06-24 | -0.00 |
| 2025-06-23 | -0.00 |
| 2025-06-20 | -0.00 |
| 2025-06-18 | -0.00 |
| 2025-06-17 | -0.00 |
| 2025-06-16 | -0.00 |
| 2025-06-13 | -0.00 |
| 2025-06-12 | -0.00 |
| 2025-06-11 | -0.00 |
| 2025-06-10 | -0.00 |
| 2025-06-09 | -0.00 |
| 2025-06-06 | -0.00 |
| 2025-06-05 | -0.00 |
| 2025-06-04 | -0.00 |
| 2025-06-03 | -0.00 |
| 2025-06-02 | -0.00 |
| 2025-05-30 | -0.00 |
| 2025-05-29 | -0.00 |
| 2025-05-28 | -0.00 |
| 2025-05-27 | -0.00 |
| 2025-05-23 | -0.00 |
| 2025-05-22 | -0.00 |
| 2025-05-21 | -0.00 |
| 2025-05-20 | -0.00 |
| 2025-05-19 | -0.00 |
| 2025-05-16 | -0.00 |
| 2025-05-15 | -0.00 |
| 2025-05-14 | -0.00 |
| 2025-05-13 | -0.00 |
| 2025-05-12 | -0.00 |
| 2025-05-09 | -0.00 |
| 2025-05-08 | -0.00 |
| 2025-05-07 | -0.00 |
| 2025-05-06 | -0.00 |
| 2025-05-05 | -0.00 |
| 2025-05-02 | -0.00 |
| 2025-05-01 | -0.00 |
| 2025-04-30 | -0.00 |
| 2025-04-29 | -0.00 |
| 2025-04-28 | -0.00 |
| 2025-04-25 | -0.00 |
| 2025-04-24 | -0.00 |
| 2025-04-23 | -0.00 |
| 2025-04-22 | -0.00 |
| 2025-04-21 | -0.00 |
| 2025-04-17 | -0.00 |